Aetna is once again trying to require adherence codes G8851, G8854 and G8855 for reimbursement for CPAP devices or supplies, the Midwest Association for Medical Equipment Services & Suppliers (MAMES) ...

ABEO READ THE FULL ABEO RESEARCH REPORT Business Update First Patient Treated with Zevaskyn® Pushed to 4Q25 The first patient treated with Zevaskyn was pushed back to the fourth quarter of 2025 ...

CMS finalized a rule that fundamentally changes Medicare payment methodology for a broad range of skin substitute products used for wound care. Beginning in January 2026, most skin substitute products ...

Find out if the company is set to experience more growth. The post Mesoblast shares surge 60% in a year. Have investors ...

First anticipated ZEVASKYN® patient treatment shifted to 4Q 2025 following implementation of optimized release assay - - Strong and growing patient demand and treatment site network, along with broad ...

Q3 2025 Earnings Call Transcript November 13, 2025 TriSalus Life Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.96 EPS, expectations were $-0.17. Operator: Good afternoon, and ...

The Centers for Medicare & Medicaid Services (“CMS”) recently finalized a Medicare payment rule with significant implications for life ...

First anticipated ZEVASKYN® patient treatment shifted to 4Q 2025 following implementation of optimized release assay - - Strong and growing patient demand and treatment site network, along with broad ...